Zenpep Shortage Update: What Patients Need to Know in 2026

If you depend on Zenpep (pancrelipase) for exocrine pancreatic insufficiency, you've likely noticed that it isn't always easy to find. Whether it's unavailable at your regular pharmacy or your pharmacist tells you it's on backorder, the experience of scrambling for an essential medication is exhausting and frightening. Here's what you need to know about Zenpep's availability status in 2026.

Is Zenpep on the FDA Shortage List in 2026?

As of 2026, Zenpep does not appear as an active drug shortage on the FDA's official Drug Shortage Database. However, this does not mean the medication is easy to find. The FDA shortage database only tracks nationwide supply disruptions — it does not reflect the real-world, localized availability problems that patients experience daily.

A pharmacy can be completely out of your specific Zenpep dose strength for days or weeks without that situation appearing on any federal tracking database. This gap between official shortage records and patient experience is one of the most frustrating realities of navigating specialty medications.

What Causes Zenpep Availability Problems?

Even without an official shortage designation, Zenpep faces structural challenges that affect availability:

• No generic version exists. Zenpep is a brand-only drug. There is no generic pancrelipase equivalent with the same formulation and FDA-approved interchangeability. Every dose must come from the same manufacturer, leaving pharmacies vulnerable to supply chain disruptions.
• Eight different dose strengths. Zenpep comes in strengths from 3,000 to 60,000 lipase units. Pharmacies must stock each individually, and smaller or rural pharmacies may carry only the most commonly prescribed strengths, leaving patients with unusual doses in the lurch.
• High per-patient consumption. Because Zenpep is taken with every meal and snack, individual patients use large quantities — often 90 to 180 capsules per month. High volume per patient means pharmacies can exhaust their stock quickly.
• Porcine-based manufacturing complexity. Pancrelipase is derived from pig pancreatic glands, which requires specialized agricultural sourcing and manufacturing oversight. Any disruption in porcine supply or production quality can ripple through to pharmacy shelves.

Has Zenpep Ever Been in an Official Shortage?

The PERT drug class — which includes Zenpep, Creon, and Pancreaze — has experienced periodic regional availability disruptions over the years. Patients with cystic fibrosis and chronic pancreatitis have historically been among the most affected, as these conditions require large daily enzyme doses that demand consistent pharmacy supply. While no major nationwide shortage of Zenpep specifically has been declared in recent years, the chronic availability challenges are well-documented in the EPI patient community.

What Should Patients Do If They Can't Find Zenpep?

If your pharmacy doesn't have Zenpep in stock, act quickly — don't wait to run out of medication before escalating. Here's the recommended sequence:

1. Use medfinder. medfinder calls pharmacies near you to identify which ones have your Zenpep strength in stock. This saves the time and stress of calling dozens of pharmacies yourself.
2. Call your prescriber. Inform your doctor that Zenpep is unavailable and ask whether they can authorize an alternative PERT — such as Creon, Pancreaze, or Pertzye — while you continue searching.
3. Ask your pharmacy to order it. Most pharmacies can place a special order for Zenpep that arrives in 1–2 business days. Request this immediately if you have a short-term supply remaining.
4. Contact the manufacturer support line. Nestlé Health Science / Aimmune Therapeutics: 1-833-246-2566. They may be able to help identify pharmacies with current inventory in your region.
5. Try mail-order or specialty pharmacies. Specialty and mail-order pharmacies that serve EPI or cystic fibrosis patients often maintain more consistent Zenpep inventory than local retail chains.

Is It Safe to Skip Zenpep Doses During a Shortage?

No. Skipping Zenpep doses is not safe for patients with true exocrine pancreatic insufficiency. Without enzyme replacement, every meal causes malabsorption of fats, proteins, and carbohydrates. Symptoms return quickly: oily, foul-smelling stools, abdominal cramps, bloating, severe weight loss, and fat-soluble vitamin deficiencies (A, D, E, K) that can have serious long-term consequences.

In children with cystic fibrosis, enzyme therapy gaps can significantly affect growth, lung function, and overall nutritional status. Never skip doses without speaking to your doctor and identifying an alternative solution first.

How to Reduce Future Shortage Risk

Proactive management can reduce the impact of availability gaps:

• Always refill at least 7–10 days before your supply runs out
• Ask your insurance plan if 90-day supplies are covered, reducing refill frequency
• Maintain a list of multiple pharmacies in your area that have carried your Zenpep strength
• Keep your prescriber's after-hours number saved in case you run out over a weekend

The Bottom Line

Zenpep is not on the FDA shortage list in 2026, but localized availability problems are common and can have serious health consequences for EPI patients. The most important steps are to refill early, use tools like medfinder to locate stock efficiently, and work with your prescriber to identify alternatives if needed. Learn more about why Zenpep is so hard to find in 2026.